Your browser doesn't support javascript.
loading
A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy.
Laouénan, C; Guedj, J; Peytavin, G; Nguyen, Th Tram; Lapalus, M; Khelifa-Mouri, F; Boyer, N; Zoulim, F; Serfaty, L; Bronowicki, J-P; Martinot-Peignoux, M; Lada, O; Asselah, T; Dorival, C; Hézode, C; Carrat, F; Nicot, F; Marcellin, P; Mentré, F.
Afiliação
  • Laouénan C; INSERM, IAME, UMR 1137, Univ Paris Diderot Sorbonne Paris Cité, Paris, France ; AP-HP, Hôpital Bichat, Departement of Biostatistic Paris, France.
  • Guedj J; INSERM, IAME, UMR 1137, Univ Paris Diderot Sorbonne Paris Cité, Paris, France.
  • Peytavin G; INSERM, IAME, UMR 1137, Univ Paris Diderot Sorbonne Paris Cité, Paris, France ; AP-HP, Hôpital Bichat, Department of Pharmaco-Toxicology Paris, France.
  • Nguyen TT; INSERM, IAME, UMR 1137, Univ Paris Diderot Sorbonne Paris Cité, Paris, France.
  • Lapalus M; INSERM, CRI Paris Montmartre, UMR 1149, Univ Paris Diderot Clichy, France.
  • Khelifa-Mouri F; AP-HP, Hôpital Beaujon, Hepatology, Physiopathology and Treatment of Viral Hepatitis Clichy, France.
  • Boyer N; AP-HP, Hôpital Beaujon, Hepatology, Physiopathology and Treatment of Viral Hepatitis Clichy, France.
  • Zoulim F; INSERM, UMR 1052, Univ Lyon Lyon, France ; Hospices Civils de Lyon, Department of Hepatology Lyon, France.
  • Serfaty L; AP-HP, Hôpital Saint-Antoine, Department of Hepatology Paris, France.
  • Bronowicki JP; INSERM, UMR 954, Univ Lorraine Vandoeuvre-les-Nancy, France ; Centre Hospitalier Universitaire de Nancy, Department of Hepatology Vandoeuvre-les-Nancy, France.
  • Martinot-Peignoux M; INSERM, CRI Paris Montmartre, UMR 1149, Univ Paris Diderot Clichy, France.
  • Lada O; INSERM, CRI Paris Montmartre, UMR 1149, Univ Paris Diderot Clichy, France.
  • Asselah T; INSERM, CRI Paris Montmartre, UMR 1149, Univ Paris Diderot Clichy, France ; AP-HP, Hôpital Beaujon, Hepatology, Physiopathology and Treatment of Viral Hepatitis Clichy, France.
  • Dorival C; INSERM, UMR 1136, Univ Pierre et Marie Curie Paris, France.
  • Hézode C; INSERM, UMR 955, Univ Paris-Est Créteil, France ; AP-HP, Hôpital Henri Mondor, Department of Hepatology Créteil, France.
  • Carrat F; INSERM, UMR 1136, Univ Pierre et Marie Curie Paris, France ; AP-HP, Hôpital Saint-Antoine, Department of Public Health Paris, France.
  • Nicot F; CHU Toulouse, IFB Purpan, Virology Laboratory Toulouse, France.
  • Marcellin P; INSERM, CRI Paris Montmartre, UMR 1149, Univ Paris Diderot Clichy, France ; AP-HP, Hôpital Beaujon, Hepatology, Physiopathology and Treatment of Viral Hepatitis Clichy, France.
  • Mentré F; INSERM, IAME, UMR 1137, Univ Paris Diderot Sorbonne Paris Cité, Paris, France ; AP-HP, Hôpital Bichat, Departement of Biostatistic Paris, France.
CPT Pharmacometrics Syst Pharmacol ; 4(1): e00008, 2015 Jan.
Article em En | MEDLINE | ID: mdl-26225222
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Ano de publicação: 2015 Tipo de documento: Article